nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—Nucleic Acid Synthesis Inhibitors—Capecitabine—prostate cancer	0.308	1	CiPCiCtD
Fluorouracil—urinary bladder cancer—prostate cancer	0.213	1	CtDrD
Fluorouracil—UMPS—prostate cancer	0.111	0.62	CbGaD
Fluorouracil—DPYD—Capecitabine—prostate cancer	0.0479	0.255	CbGbCtD
Fluorouracil—TYMP—Capecitabine—prostate cancer	0.0318	0.17	CbGbCtD
Fluorouracil—TYMS—prostate cancer	0.0275	0.153	CbGaD
Fluorouracil—MTHFR—prostate cancer	0.0219	0.122	CbGaD
Fluorouracil—CYP2A6—prostate cancer	0.0187	0.104	CbGaD
Fluorouracil—TYMS—Capecitabine—prostate cancer	0.0169	0.0903	CbGbCtD
Fluorouracil—ABCC3—Conjugated Estrogens—prostate cancer	0.00758	0.0404	CbGbCtD
Fluorouracil—ABCC4—Conjugated Estrogens—prostate cancer	0.00579	0.0309	CbGbCtD
Fluorouracil—ABCG2—Cabazitaxel—prostate cancer	0.00487	0.026	CbGbCtD
Fluorouracil—ABCG2—Estrone—prostate cancer	0.00476	0.0254	CbGbCtD
Fluorouracil—ALB—Abiraterone—prostate cancer	0.00454	0.0242	CbGbCtD
Fluorouracil—ABCC3—Etoposide—prostate cancer	0.00435	0.0232	CbGbCtD
Fluorouracil—CYP2C8—Nilutamide—prostate cancer	0.00423	0.0226	CbGbCtD
Fluorouracil—CYP2C8—Abiraterone—prostate cancer	0.00351	0.0187	CbGbCtD
Fluorouracil—ALB—Estrone—prostate cancer	0.00328	0.0175	CbGbCtD
Fluorouracil—ABCG2—Conjugated Estrogens—prostate cancer	0.00311	0.0166	CbGbCtD
Fluorouracil—SLC22A7—Docetaxel—prostate cancer	0.00311	0.0166	CbGbCtD
Fluorouracil—ABCC3—Doxorubicin—prostate cancer	0.00296	0.0158	CbGbCtD
Fluorouracil—CYP2C9—Bicalutamide—prostate cancer	0.00295	0.0157	CbGbCtD
Fluorouracil—CYP2C9—Nilutamide—prostate cancer	0.00295	0.0157	CbGbCtD
Fluorouracil—ABCG2—Mitoxantrone—prostate cancer	0.00283	0.0151	CbGbCtD
Fluorouracil—ABCG2—Estradiol—prostate cancer	0.00273	0.0146	CbGbCtD
Fluorouracil—CYP1A2—Flutamide—prostate cancer	0.00272	0.0145	CbGbCtD
Fluorouracil—CYP2C8—Cabazitaxel—prostate cancer	0.00259	0.0138	CbGbCtD
Fluorouracil—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00226	0.012	CbGbCtD
Fluorouracil—CYP1A2—Estrone—prostate cancer	0.00196	0.0105	CbGbCtD
Fluorouracil—ALB—Estradiol—prostate cancer	0.00188	0.01	CbGbCtD
Fluorouracil—ABCG2—Etoposide—prostate cancer	0.00179	0.00952	CbGbCtD
Fluorouracil—CYP2C9—Estrone—prostate cancer	0.00177	0.00943	CbGbCtD
Fluorouracil—ABCG2—Docetaxel—prostate cancer	0.00163	0.00871	CbGbCtD
Fluorouracil—ALB—Prednisone—prostate cancer	0.00162	0.00864	CbGbCtD
Fluorouracil—CYP2C8—Estradiol—prostate cancer	0.00146	0.00776	CbGbCtD
Fluorouracil—CYP2C9—Capecitabine—prostate cancer	0.00134	0.00715	CbGbCtD
Fluorouracil—CYP1A2—Conjugated Estrogens—prostate cancer	0.00128	0.00685	CbGbCtD
Fluorouracil—ABCG2—Doxorubicin—prostate cancer	0.00122	0.00649	CbGbCtD
Fluorouracil—UPP2—renal system—prostate cancer	0.00115	0.0585	CbGeAlD
Fluorouracil—CYP1A2—Estradiol—prostate cancer	0.00113	0.00601	CbGbCtD
Fluorouracil—CYP2C9—Estradiol—prostate cancer	0.00102	0.00542	CbGbCtD
Fluorouracil—UMPS—prostate gland—prostate cancer	0.000955	0.0487	CbGeAlD
Fluorouracil—CYP2C8—Etoposide—prostate cancer	0.000951	0.00507	CbGbCtD
Fluorouracil—UPP1—prostate gland—prostate cancer	0.000876	0.0446	CbGeAlD
Fluorouracil—UPP1—seminal vesicle—prostate cancer	0.000741	0.0377	CbGeAlD
Fluorouracil—CYP1A2—Etoposide—prostate cancer	0.000736	0.00392	CbGbCtD
Fluorouracil—DPYD—prostate gland—prostate cancer	0.000711	0.0362	CbGeAlD
Fluorouracil—PPAT—prostate gland—prostate cancer	0.000616	0.0314	CbGeAlD
Fluorouracil—UPP1—urethra—prostate cancer	0.000586	0.0299	CbGeAlD
Fluorouracil—PPAT—seminal vesicle—prostate cancer	0.000521	0.0265	CbGeAlD
Fluorouracil—UMPS—bone marrow—prostate cancer	0.000492	0.0251	CbGeAlD
Fluorouracil—CYP1A2—urine—prostate cancer	0.000453	0.0231	CbGeAlD
Fluorouracil—UPP1—bone marrow—prostate cancer	0.000451	0.023	CbGeAlD
Fluorouracil—CYP2C9—urine—prostate cancer	0.00043	0.0219	CbGeAlD
Fluorouracil—UMPS—testis—prostate cancer	0.000421	0.0214	CbGeAlD
Fluorouracil—TYMP—prostate gland—prostate cancer	0.000412	0.021	CbGeAlD
Fluorouracil—MTHFR—prostate gland—prostate cancer	0.000387	0.0197	CbGeAlD
Fluorouracil—UPP1—testis—prostate cancer	0.000386	0.0197	CbGeAlD
Fluorouracil—DPYD—bone marrow—prostate cancer	0.000367	0.0187	CbGeAlD
Fluorouracil—TYMS—prostate gland—prostate cancer	0.000354	0.018	CbGeAlD
Fluorouracil—TYMP—seminal vesicle—prostate cancer	0.000349	0.0178	CbGeAlD
Fluorouracil—ABCC5—prostate gland—prostate cancer	0.000345	0.0176	CbGeAlD
Fluorouracil—PPAT—bone marrow—prostate cancer	0.000317	0.0162	CbGeAlD
Fluorouracil—SLC29A1—prostate gland—prostate cancer	0.000317	0.0162	CbGeAlD
Fluorouracil—DPYD—testis—prostate cancer	0.000313	0.016	CbGeAlD
Fluorouracil—CYP2A6—prostate gland—prostate cancer	0.00031	0.0158	CbGeAlD
Fluorouracil—UMPS—lymph node—prostate cancer	0.000305	0.0155	CbGeAlD
Fluorouracil—ABCC3—prostate gland—prostate cancer	0.00029	0.0148	CbGeAlD
Fluorouracil—SLC22A7—renal system—prostate cancer	0.00028	0.0143	CbGeAlD
Fluorouracil—UPP1—lymph node—prostate cancer	0.00028	0.0142	CbGeAlD
Fluorouracil—TYMP—urethra—prostate cancer	0.000276	0.0141	CbGeAlD
Fluorouracil—PPAT—testis—prostate cancer	0.000271	0.0138	CbGeAlD
Fluorouracil—CYP2A6—seminal vesicle—prostate cancer	0.000262	0.0133	CbGeAlD
Fluorouracil—ABCC4—prostate gland—prostate cancer	0.000239	0.0122	CbGeAlD
Fluorouracil—DPYD—lymph node—prostate cancer	0.000227	0.0116	CbGeAlD
Fluorouracil—SLC29A1—renal system—prostate cancer	0.000216	0.011	CbGeAlD
Fluorouracil—TYMP—bone marrow—prostate cancer	0.000212	0.0108	CbGeAlD
Fluorouracil—SLC29A1—urethra—prostate cancer	0.000212	0.0108	CbGeAlD
Fluorouracil—ABCC3—renal system—prostate cancer	0.000198	0.0101	CbGeAlD
Fluorouracil—TYMS—Docetaxel—Cabazitaxel—prostate cancer	0.000197	0.197	CbGdCrCtD
Fluorouracil—PPAT—lymph node—prostate cancer	0.000197	0.01	CbGeAlD
Fluorouracil—TYMS—bone marrow—prostate cancer	0.000182	0.00928	CbGeAlD
Fluorouracil—TYMP—testis—prostate cancer	0.000182	0.00925	CbGeAlD
Fluorouracil—SLC22A7—testis—prostate cancer	0.000181	0.00922	CbGeAlD
Fluorouracil—ABCC5—bone marrow—prostate cancer	0.000178	0.00907	CbGeAlD
Fluorouracil—MTHFR—testis—prostate cancer	0.000171	0.0087	CbGeAlD
Fluorouracil—ABCG2—prostate gland—prostate cancer	0.000169	0.00861	CbGeAlD
Fluorouracil—SLC29A1—bone marrow—prostate cancer	0.000163	0.00832	CbGeAlD
Fluorouracil—ABCC4—renal system—prostate cancer	0.000163	0.00831	CbGeAlD
Fluorouracil—TYMS—testis—prostate cancer	0.000156	0.00794	CbGeAlD
Fluorouracil—ABCC5—testis—prostate cancer	0.000152	0.00775	CbGeAlD
Fluorouracil—ABCG2—seminal vesicle—prostate cancer	0.000143	0.00728	CbGeAlD
Fluorouracil—SLC29A1—testis—prostate cancer	0.00014	0.00712	CbGeAlD
Fluorouracil—TYMS—Paclitaxel—Cabazitaxel—prostate cancer	0.000136	0.136	CbGdCrCtD
Fluorouracil—TYMP—lymph node—prostate cancer	0.000132	0.0067	CbGeAlD
Fluorouracil—ABCC3—testis—prostate cancer	0.000128	0.00651	CbGeAlD
Fluorouracil—MTHFR—lymph node—prostate cancer	0.000124	0.0063	CbGeAlD
Fluorouracil—ABCC4—bone marrow—prostate cancer	0.000123	0.00628	CbGeAlD
Fluorouracil—CYP2C8—renal system—prostate cancer	0.000118	0.00603	CbGeAlD
Fluorouracil—ABCG2—urethra—prostate cancer	0.000113	0.00576	CbGeAlD
Fluorouracil—TYMS—lymph node—prostate cancer	0.000113	0.00575	CbGeAlD
Fluorouracil—CYP1A2—renal system—prostate cancer	0.000111	0.00565	CbGeAlD
Fluorouracil—ABCC5—lymph node—prostate cancer	0.00011	0.00562	CbGeAlD
Fluorouracil—ALB—testis—prostate cancer	0.000109	0.00555	CbGeAlD
Fluorouracil—ABCC4—testis—prostate cancer	0.000105	0.00537	CbGeAlD
Fluorouracil—SLC29A1—lymph node—prostate cancer	0.000101	0.00516	CbGeAlD
Fluorouracil—ABCC3—lymph node—prostate cancer	9.26e-05	0.00472	CbGeAlD
Fluorouracil—ABCG2—bone marrow—prostate cancer	8.71e-05	0.00444	CbGeAlD
Fluorouracil—ALB—lymph node—prostate cancer	7.9e-05	0.00402	CbGeAlD
Fluorouracil—CYP2C8—testis—prostate cancer	7.66e-05	0.0039	CbGeAlD
Fluorouracil—ABCC4—lymph node—prostate cancer	7.64e-05	0.00389	CbGeAlD
Fluorouracil—UMPS—Daunorubicin—Epirubicin—prostate cancer	7.57e-05	0.0755	CbGdCrCtD
Fluorouracil—UMPS—Idarubicin—Epirubicin—prostate cancer	7.57e-05	0.0755	CbGdCrCtD
Fluorouracil—UMPS—Doxorubicin—Epirubicin—prostate cancer	7.57e-05	0.0755	CbGdCrCtD
Fluorouracil—ABCG2—testis—prostate cancer	7.44e-05	0.00379	CbGeAlD
Fluorouracil—UMPS—Daunorubicin—Doxorubicin—prostate cancer	7e-05	0.0698	CbGdCrCtD
Fluorouracil—UMPS—Epirubicin—Doxorubicin—prostate cancer	7e-05	0.0698	CbGdCrCtD
Fluorouracil—UMPS—Idarubicin—Doxorubicin—prostate cancer	7e-05	0.0698	CbGdCrCtD
Fluorouracil—TYMS—Paclitaxel—Docetaxel—prostate cancer	5.65e-05	0.0564	CbGdCrCtD
Fluorouracil—ABCG2—lymph node—prostate cancer	5.4e-05	0.00275	CbGeAlD
Fluorouracil—TYMS—Podofilox—Etoposide—prostate cancer	3.63e-05	0.0362	CbGdCrCtD
Fluorouracil—TYMS—Levorphanol—Estrone—prostate cancer	3.6e-05	0.0359	CbGdCrCtD
Fluorouracil—TYMS—Levorphanol—Estradiol—prostate cancer	2.72e-05	0.0272	CbGdCrCtD
Fluorouracil—TYMS—Danazol—Ethinyl Estradiol—prostate cancer	1.8e-05	0.018	CbGdCrCtD
Fluorouracil—Muscular weakness—Doxorubicin—prostate cancer	1.54e-05	0.000311	CcSEcCtD
Fluorouracil—Vision blurred—Capecitabine—prostate cancer	1.54e-05	0.000311	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Epirubicin—prostate cancer	1.51e-05	0.000307	CcSEcCtD
Fluorouracil—Pruritus—Estradiol—prostate cancer	1.51e-05	0.000305	CcSEcCtD
Fluorouracil—Dysphagia—Doxorubicin—prostate cancer	1.51e-05	0.000305	CcSEcCtD
Fluorouracil—Leukopenia—Docetaxel—prostate cancer	1.51e-05	0.000305	CcSEcCtD
Fluorouracil—Anaemia—Capecitabine—prostate cancer	1.51e-05	0.000305	CcSEcCtD
Fluorouracil—Eosinophilia—Doxorubicin—prostate cancer	1.49e-05	0.000302	CcSEcCtD
Fluorouracil—Arrhythmia—Prednisone—prostate cancer	1.49e-05	0.000302	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Epirubicin—prostate cancer	1.49e-05	0.000301	CcSEcCtD
Fluorouracil—Paraesthesia—Etoposide—prostate cancer	1.48e-05	0.0003	CcSEcCtD
Fluorouracil—Dyspnoea—Etoposide—prostate cancer	1.47e-05	0.000298	CcSEcCtD
Fluorouracil—Alopecia—Prednisone—prostate cancer	1.47e-05	0.000298	CcSEcCtD
Fluorouracil—Somnolence—Etoposide—prostate cancer	1.47e-05	0.000297	CcSEcCtD
Fluorouracil—Angina pectoris—Doxorubicin—prostate cancer	1.47e-05	0.000297	CcSEcCtD
Fluorouracil—Hypersensitivity—Mitoxantrone—prostate cancer	1.46e-05	0.000296	CcSEcCtD
Fluorouracil—Pneumonia—Epirubicin—prostate cancer	1.46e-05	0.000296	CcSEcCtD
Fluorouracil—Diarrhoea—Estradiol—prostate cancer	1.46e-05	0.000295	CcSEcCtD
Fluorouracil—Leukopenia—Capecitabine—prostate cancer	1.46e-05	0.000295	CcSEcCtD
Fluorouracil—Convulsion—Docetaxel—prostate cancer	1.46e-05	0.000295	CcSEcCtD
Fluorouracil—Infestation NOS—Epirubicin—prostate cancer	1.45e-05	0.000294	CcSEcCtD
Fluorouracil—Infestation—Epirubicin—prostate cancer	1.45e-05	0.000294	CcSEcCtD
Fluorouracil—Erythema—Prednisone—prostate cancer	1.45e-05	0.000294	CcSEcCtD
Fluorouracil—Decreased appetite—Etoposide—prostate cancer	1.44e-05	0.000291	CcSEcCtD
Fluorouracil—Myalgia—Docetaxel—prostate cancer	1.43e-05	0.00029	CcSEcCtD
Fluorouracil—Chest pain—Docetaxel—prostate cancer	1.43e-05	0.00029	CcSEcCtD
Fluorouracil—Pancytopenia—Doxorubicin—prostate cancer	1.43e-05	0.00029	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Etoposide—prostate cancer	1.43e-05	0.000289	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Epirubicin—prostate cancer	1.42e-05	0.000288	CcSEcCtD
Fluorouracil—Stomatitis—Epirubicin—prostate cancer	1.42e-05	0.000287	CcSEcCtD
Fluorouracil—Pain—Etoposide—prostate cancer	1.41e-05	0.000286	CcSEcCtD
Fluorouracil—Conjunctivitis—Epirubicin—prostate cancer	1.41e-05	0.000286	CcSEcCtD
Fluorouracil—Urinary tract infection—Epirubicin—prostate cancer	1.41e-05	0.000286	CcSEcCtD
Fluorouracil—Dizziness—Estradiol—prostate cancer	1.41e-05	0.000286	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Doxorubicin—prostate cancer	1.4e-05	0.000284	CcSEcCtD
Fluorouracil—Chest pain—Capecitabine—prostate cancer	1.39e-05	0.000281	CcSEcCtD
Fluorouracil—Myalgia—Capecitabine—prostate cancer	1.39e-05	0.000281	CcSEcCtD
Fluorouracil—Confusional state—Docetaxel—prostate cancer	1.38e-05	0.00028	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Doxorubicin—prostate cancer	1.38e-05	0.000279	CcSEcCtD
Fluorouracil—Anaphylactic shock—Docetaxel—prostate cancer	1.37e-05	0.000278	CcSEcCtD
Fluorouracil—Oedema—Docetaxel—prostate cancer	1.37e-05	0.000278	CcSEcCtD
Fluorouracil—Discomfort—Capecitabine—prostate cancer	1.37e-05	0.000278	CcSEcCtD
Fluorouracil—Epistaxis—Epirubicin—prostate cancer	1.37e-05	0.000277	CcSEcCtD
Fluorouracil—Vision blurred—Prednisone—prostate cancer	1.37e-05	0.000277	CcSEcCtD
Fluorouracil—Infection—Docetaxel—prostate cancer	1.36e-05	0.000276	CcSEcCtD
Fluorouracil—Sinusitis—Epirubicin—prostate cancer	1.36e-05	0.000276	CcSEcCtD
Fluorouracil—Feeling abnormal—Etoposide—prostate cancer	1.36e-05	0.000276	CcSEcCtD
Fluorouracil—Diarrhoea—Mitoxantrone—prostate cancer	1.36e-05	0.000275	CcSEcCtD
Fluorouracil—Vomiting—Estradiol—prostate cancer	1.36e-05	0.000275	CcSEcCtD
Fluorouracil—Agranulocytosis—Epirubicin—prostate cancer	1.36e-05	0.000274	CcSEcCtD
Fluorouracil—Pneumonia—Doxorubicin—prostate cancer	1.35e-05	0.000274	CcSEcCtD
Fluorouracil—Nervous system disorder—Docetaxel—prostate cancer	1.35e-05	0.000273	CcSEcCtD
Fluorouracil—Thrombocytopenia—Docetaxel—prostate cancer	1.34e-05	0.000272	CcSEcCtD
Fluorouracil—Rash—Estradiol—prostate cancer	1.34e-05	0.000272	CcSEcCtD
Fluorouracil—Infestation NOS—Doxorubicin—prostate cancer	1.34e-05	0.000272	CcSEcCtD
Fluorouracil—Infestation—Doxorubicin—prostate cancer	1.34e-05	0.000272	CcSEcCtD
Fluorouracil—Dermatitis—Estradiol—prostate cancer	1.34e-05	0.000272	CcSEcCtD
Fluorouracil—Anaemia—Prednisone—prostate cancer	1.34e-05	0.000272	CcSEcCtD
Fluorouracil—Confusional state—Capecitabine—prostate cancer	1.34e-05	0.000271	CcSEcCtD
Fluorouracil—Tachycardia—Docetaxel—prostate cancer	1.34e-05	0.000271	CcSEcCtD
Fluorouracil—Headache—Estradiol—prostate cancer	1.34e-05	0.00027	CcSEcCtD
Fluorouracil—Oedema—Capecitabine—prostate cancer	1.33e-05	0.000269	CcSEcCtD
Fluorouracil—Infection—Capecitabine—prostate cancer	1.32e-05	0.000268	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Doxorubicin—prostate cancer	1.32e-05	0.000267	CcSEcCtD
Fluorouracil—Urticaria—Etoposide—prostate cancer	1.31e-05	0.000266	CcSEcCtD
Fluorouracil—Haemoglobin—Epirubicin—prostate cancer	1.31e-05	0.000265	CcSEcCtD
Fluorouracil—Stomatitis—Doxorubicin—prostate cancer	1.31e-05	0.000265	CcSEcCtD
Fluorouracil—Anorexia—Docetaxel—prostate cancer	1.31e-05	0.000265	CcSEcCtD
Fluorouracil—Rhinitis—Epirubicin—prostate cancer	1.31e-05	0.000265	CcSEcCtD
Fluorouracil—Body temperature increased—Etoposide—prostate cancer	1.31e-05	0.000265	CcSEcCtD
Fluorouracil—Conjunctivitis—Doxorubicin—prostate cancer	1.31e-05	0.000265	CcSEcCtD
Fluorouracil—Urinary tract infection—Doxorubicin—prostate cancer	1.31e-05	0.000265	CcSEcCtD
Fluorouracil—Nervous system disorder—Capecitabine—prostate cancer	1.3e-05	0.000264	CcSEcCtD
Fluorouracil—Haemorrhage—Epirubicin—prostate cancer	1.3e-05	0.000264	CcSEcCtD
Fluorouracil—Thrombocytopenia—Capecitabine—prostate cancer	1.3e-05	0.000264	CcSEcCtD
Fluorouracil—Tachycardia—Capecitabine—prostate cancer	1.3e-05	0.000263	CcSEcCtD
Fluorouracil—Hypoaesthesia—Epirubicin—prostate cancer	1.3e-05	0.000263	CcSEcCtD
Fluorouracil—Pharyngitis—Epirubicin—prostate cancer	1.29e-05	0.000262	CcSEcCtD
Fluorouracil—TYMS—Levonorgestrel—Ethinyl Estradiol—prostate cancer	1.29e-05	0.0129	CbGdCrCtD
Fluorouracil—Hypotension—Docetaxel—prostate cancer	1.28e-05	0.00026	CcSEcCtD
Fluorouracil—Epistaxis—Doxorubicin—prostate cancer	1.27e-05	0.000257	CcSEcCtD
Fluorouracil—Anorexia—Capecitabine—prostate cancer	1.27e-05	0.000257	CcSEcCtD
Fluorouracil—Nausea—Estradiol—prostate cancer	1.27e-05	0.000256	CcSEcCtD
Fluorouracil—Vomiting—Mitoxantrone—prostate cancer	1.26e-05	0.000256	CcSEcCtD
Fluorouracil—Sinusitis—Doxorubicin—prostate cancer	1.26e-05	0.000255	CcSEcCtD
Fluorouracil—Convulsion—Prednisone—prostate cancer	1.26e-05	0.000255	CcSEcCtD
Fluorouracil—Agranulocytosis—Doxorubicin—prostate cancer	1.25e-05	0.000254	CcSEcCtD
Fluorouracil—Rash—Mitoxantrone—prostate cancer	1.25e-05	0.000254	CcSEcCtD
Fluorouracil—Dermatitis—Mitoxantrone—prostate cancer	1.25e-05	0.000253	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Docetaxel—prostate cancer	1.25e-05	0.000253	CcSEcCtD
Fluorouracil—Headache—Mitoxantrone—prostate cancer	1.24e-05	0.000252	CcSEcCtD
Fluorouracil—Hypotension—Capecitabine—prostate cancer	1.24e-05	0.000252	CcSEcCtD
Fluorouracil—Insomnia—Docetaxel—prostate cancer	1.24e-05	0.000252	CcSEcCtD
Fluorouracil—Myalgia—Prednisone—prostate cancer	1.24e-05	0.00025	CcSEcCtD
Fluorouracil—Paraesthesia—Docetaxel—prostate cancer	1.23e-05	0.00025	CcSEcCtD
Fluorouracil—Dyspnoea—Docetaxel—prostate cancer	1.22e-05	0.000248	CcSEcCtD
Fluorouracil—Somnolence—Docetaxel—prostate cancer	1.22e-05	0.000247	CcSEcCtD
Fluorouracil—Discomfort—Prednisone—prostate cancer	1.22e-05	0.000247	CcSEcCtD
Fluorouracil—Hypersensitivity—Etoposide—prostate cancer	1.22e-05	0.000247	CcSEcCtD
Fluorouracil—Haemoglobin—Doxorubicin—prostate cancer	1.21e-05	0.000246	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Capecitabine—prostate cancer	1.21e-05	0.000245	CcSEcCtD
Fluorouracil—Rhinitis—Doxorubicin—prostate cancer	1.21e-05	0.000245	CcSEcCtD
Fluorouracil—Dyspepsia—Docetaxel—prostate cancer	1.21e-05	0.000245	CcSEcCtD
Fluorouracil—Haemorrhage—Doxorubicin—prostate cancer	1.21e-05	0.000244	CcSEcCtD
Fluorouracil—Insomnia—Capecitabine—prostate cancer	1.2e-05	0.000244	CcSEcCtD
Fluorouracil—Hypoaesthesia—Doxorubicin—prostate cancer	1.2e-05	0.000243	CcSEcCtD
Fluorouracil—Pharyngitis—Doxorubicin—prostate cancer	1.2e-05	0.000242	CcSEcCtD
Fluorouracil—Paraesthesia—Capecitabine—prostate cancer	1.19e-05	0.000242	CcSEcCtD
Fluorouracil—Decreased appetite—Docetaxel—prostate cancer	1.19e-05	0.000242	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Docetaxel—prostate cancer	1.19e-05	0.00024	CcSEcCtD
Fluorouracil—Dyspnoea—Capecitabine—prostate cancer	1.19e-05	0.00024	CcSEcCtD
Fluorouracil—Anaphylactic shock—Prednisone—prostate cancer	1.18e-05	0.00024	CcSEcCtD
Fluorouracil—Oedema—Prednisone—prostate cancer	1.18e-05	0.00024	CcSEcCtD
Fluorouracil—Nausea—Mitoxantrone—prostate cancer	1.18e-05	0.000239	CcSEcCtD
Fluorouracil—Infection—Prednisone—prostate cancer	1.18e-05	0.000238	CcSEcCtD
Fluorouracil—Pain—Docetaxel—prostate cancer	1.17e-05	0.000238	CcSEcCtD
Fluorouracil—Dyspepsia—Capecitabine—prostate cancer	1.17e-05	0.000237	CcSEcCtD
Fluorouracil—Pruritus—Etoposide—prostate cancer	1.17e-05	0.000237	CcSEcCtD
Fluorouracil—Arrhythmia—Epirubicin—prostate cancer	1.16e-05	0.000236	CcSEcCtD
Fluorouracil—Nervous system disorder—Prednisone—prostate cancer	1.16e-05	0.000235	CcSEcCtD
Fluorouracil—Tachycardia—Prednisone—prostate cancer	1.16e-05	0.000234	CcSEcCtD
Fluorouracil—Decreased appetite—Capecitabine—prostate cancer	1.16e-05	0.000234	CcSEcCtD
Fluorouracil—Alopecia—Epirubicin—prostate cancer	1.15e-05	0.000233	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Capecitabine—prostate cancer	1.15e-05	0.000232	CcSEcCtD
Fluorouracil—Pain—Capecitabine—prostate cancer	1.14e-05	0.00023	CcSEcCtD
Fluorouracil—Erythema—Epirubicin—prostate cancer	1.14e-05	0.00023	CcSEcCtD
Fluorouracil—Feeling abnormal—Docetaxel—prostate cancer	1.13e-05	0.000229	CcSEcCtD
Fluorouracil—Diarrhoea—Etoposide—prostate cancer	1.13e-05	0.000229	CcSEcCtD
Fluorouracil—Anorexia—Prednisone—prostate cancer	1.13e-05	0.000229	CcSEcCtD
Fluorouracil—Feeling abnormal—Capecitabine—prostate cancer	1.1e-05	0.000222	CcSEcCtD
Fluorouracil—Dizziness—Etoposide—prostate cancer	1.09e-05	0.000221	CcSEcCtD
Fluorouracil—Body temperature increased—Docetaxel—prostate cancer	1.09e-05	0.00022	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Prednisone—prostate cancer	1.08e-05	0.000219	CcSEcCtD
Fluorouracil—Arrhythmia—Doxorubicin—prostate cancer	1.08e-05	0.000218	CcSEcCtD
Fluorouracil—Insomnia—Prednisone—prostate cancer	1.07e-05	0.000217	CcSEcCtD
Fluorouracil—Vision blurred—Epirubicin—prostate cancer	1.07e-05	0.000217	CcSEcCtD
Fluorouracil—Alopecia—Doxorubicin—prostate cancer	1.07e-05	0.000216	CcSEcCtD
Fluorouracil—Paraesthesia—Prednisone—prostate cancer	1.06e-05	0.000215	CcSEcCtD
Fluorouracil—Urticaria—Capecitabine—prostate cancer	1.06e-05	0.000214	CcSEcCtD
Fluorouracil—Body temperature increased—Capecitabine—prostate cancer	1.05e-05	0.000213	CcSEcCtD
Fluorouracil—Vomiting—Etoposide—prostate cancer	1.05e-05	0.000213	CcSEcCtD
Fluorouracil—Erythema—Doxorubicin—prostate cancer	1.05e-05	0.000213	CcSEcCtD
Fluorouracil—Anaemia—Epirubicin—prostate cancer	1.05e-05	0.000212	CcSEcCtD
Fluorouracil—Dyspepsia—Prednisone—prostate cancer	1.04e-05	0.000211	CcSEcCtD
Fluorouracil—Rash—Etoposide—prostate cancer	1.04e-05	0.000211	CcSEcCtD
Fluorouracil—Dermatitis—Etoposide—prostate cancer	1.04e-05	0.000211	CcSEcCtD
Fluorouracil—Headache—Etoposide—prostate cancer	1.04e-05	0.00021	CcSEcCtD
Fluorouracil—Decreased appetite—Prednisone—prostate cancer	1.03e-05	0.000208	CcSEcCtD
Fluorouracil—Leukopenia—Epirubicin—prostate cancer	1.02e-05	0.000206	CcSEcCtD
Fluorouracil—Hypersensitivity—Docetaxel—prostate cancer	1.01e-05	0.000205	CcSEcCtD
Fluorouracil—Vision blurred—Doxorubicin—prostate cancer	9.9e-06	0.0002	CcSEcCtD
Fluorouracil—Convulsion—Epirubicin—prostate cancer	9.84e-06	0.000199	CcSEcCtD
Fluorouracil—Nausea—Etoposide—prostate cancer	9.82e-06	0.000199	CcSEcCtD
Fluorouracil—Hypersensitivity—Capecitabine—prostate cancer	9.8e-06	0.000198	CcSEcCtD
Fluorouracil—Feeling abnormal—Prednisone—prostate cancer	9.76e-06	0.000198	CcSEcCtD
Fluorouracil—Pruritus—Docetaxel—prostate cancer	9.72e-06	0.000197	CcSEcCtD
Fluorouracil—Anaemia—Doxorubicin—prostate cancer	9.71e-06	0.000197	CcSEcCtD
Fluorouracil—Myalgia—Epirubicin—prostate cancer	9.66e-06	0.000196	CcSEcCtD
Fluorouracil—Chest pain—Epirubicin—prostate cancer	9.66e-06	0.000196	CcSEcCtD
Fluorouracil—Discomfort—Epirubicin—prostate cancer	9.55e-06	0.000193	CcSEcCtD
Fluorouracil—Urticaria—Prednisone—prostate cancer	9.41e-06	0.000191	CcSEcCtD
Fluorouracil—Pruritus—Capecitabine—prostate cancer	9.41e-06	0.000191	CcSEcCtD
Fluorouracil—Leukopenia—Doxorubicin—prostate cancer	9.4e-06	0.00019	CcSEcCtD
Fluorouracil—Diarrhoea—Docetaxel—prostate cancer	9.4e-06	0.00019	CcSEcCtD
Fluorouracil—Body temperature increased—Prednisone—prostate cancer	9.36e-06	0.00019	CcSEcCtD
Fluorouracil—Confusional state—Epirubicin—prostate cancer	9.34e-06	0.000189	CcSEcCtD
Fluorouracil—Anaphylactic shock—Epirubicin—prostate cancer	9.26e-06	0.000188	CcSEcCtD
Fluorouracil—Oedema—Epirubicin—prostate cancer	9.26e-06	0.000188	CcSEcCtD
Fluorouracil—Infection—Epirubicin—prostate cancer	9.2e-06	0.000186	CcSEcCtD
Fluorouracil—Convulsion—Doxorubicin—prostate cancer	9.1e-06	0.000184	CcSEcCtD
Fluorouracil—Diarrhoea—Capecitabine—prostate cancer	9.1e-06	0.000184	CcSEcCtD
Fluorouracil—Nervous system disorder—Epirubicin—prostate cancer	9.09e-06	0.000184	CcSEcCtD
Fluorouracil—Dizziness—Docetaxel—prostate cancer	9.08e-06	0.000184	CcSEcCtD
Fluorouracil—Thrombocytopenia—Epirubicin—prostate cancer	9.07e-06	0.000184	CcSEcCtD
Fluorouracil—Tachycardia—Epirubicin—prostate cancer	9.04e-06	0.000183	CcSEcCtD
Fluorouracil—Chest pain—Doxorubicin—prostate cancer	8.94e-06	0.000181	CcSEcCtD
Fluorouracil—Myalgia—Doxorubicin—prostate cancer	8.94e-06	0.000181	CcSEcCtD
Fluorouracil—Discomfort—Doxorubicin—prostate cancer	8.83e-06	0.000179	CcSEcCtD
Fluorouracil—Anorexia—Epirubicin—prostate cancer	8.83e-06	0.000179	CcSEcCtD
Fluorouracil—Dizziness—Capecitabine—prostate cancer	8.79e-06	0.000178	CcSEcCtD
Fluorouracil—Vomiting—Docetaxel—prostate cancer	8.73e-06	0.000177	CcSEcCtD
Fluorouracil—Hypersensitivity—Prednisone—prostate cancer	8.73e-06	0.000177	CcSEcCtD
Fluorouracil—Rash—Docetaxel—prostate cancer	8.66e-06	0.000175	CcSEcCtD
Fluorouracil—Hypotension—Epirubicin—prostate cancer	8.66e-06	0.000175	CcSEcCtD
Fluorouracil—Dermatitis—Docetaxel—prostate cancer	8.65e-06	0.000175	CcSEcCtD
Fluorouracil—Confusional state—Doxorubicin—prostate cancer	8.64e-06	0.000175	CcSEcCtD
Fluorouracil—Headache—Docetaxel—prostate cancer	8.6e-06	0.000174	CcSEcCtD
Fluorouracil—Anaphylactic shock—Doxorubicin—prostate cancer	8.57e-06	0.000174	CcSEcCtD
Fluorouracil—Oedema—Doxorubicin—prostate cancer	8.57e-06	0.000174	CcSEcCtD
Fluorouracil—Infection—Doxorubicin—prostate cancer	8.52e-06	0.000172	CcSEcCtD
Fluorouracil—Vomiting—Capecitabine—prostate cancer	8.46e-06	0.000171	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Epirubicin—prostate cancer	8.44e-06	0.000171	CcSEcCtD
Fluorouracil—Nervous system disorder—Doxorubicin—prostate cancer	8.41e-06	0.00017	CcSEcCtD
Fluorouracil—Thrombocytopenia—Doxorubicin—prostate cancer	8.39e-06	0.00017	CcSEcCtD
Fluorouracil—Rash—Capecitabine—prostate cancer	8.38e-06	0.00017	CcSEcCtD
Fluorouracil—Pruritus—Prednisone—prostate cancer	8.38e-06	0.00017	CcSEcCtD
Fluorouracil—Insomnia—Epirubicin—prostate cancer	8.38e-06	0.00017	CcSEcCtD
Fluorouracil—Dermatitis—Capecitabine—prostate cancer	8.38e-06	0.00017	CcSEcCtD
Fluorouracil—Tachycardia—Doxorubicin—prostate cancer	8.37e-06	0.000169	CcSEcCtD
Fluorouracil—TYMS—Clobetasol propionate—Prednisone—prostate cancer	8.36e-06	0.00834	CbGdCrCtD
Fluorouracil—Headache—Capecitabine—prostate cancer	8.33e-06	0.000169	CcSEcCtD
Fluorouracil—Paraesthesia—Epirubicin—prostate cancer	8.32e-06	0.000168	CcSEcCtD
Fluorouracil—Dyspnoea—Epirubicin—prostate cancer	8.26e-06	0.000167	CcSEcCtD
Fluorouracil—TYMS—Flunisolide—Prednisone—prostate cancer	8.25e-06	0.00823	CbGdCrCtD
Fluorouracil—Somnolence—Epirubicin—prostate cancer	8.24e-06	0.000167	CcSEcCtD
Fluorouracil—Anorexia—Doxorubicin—prostate cancer	8.17e-06	0.000165	CcSEcCtD
Fluorouracil—TYMS—Triamcinolone—Prednisone—prostate cancer	8.16e-06	0.00814	CbGdCrCtD
Fluorouracil—Nausea—Docetaxel—prostate cancer	8.16e-06	0.000165	CcSEcCtD
Fluorouracil—Dyspepsia—Epirubicin—prostate cancer	8.15e-06	0.000165	CcSEcCtD
Fluorouracil—Diarrhoea—Prednisone—prostate cancer	8.1e-06	0.000164	CcSEcCtD
Fluorouracil—Decreased appetite—Epirubicin—prostate cancer	8.05e-06	0.000163	CcSEcCtD
Fluorouracil—Hypotension—Doxorubicin—prostate cancer	8.01e-06	0.000162	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Epirubicin—prostate cancer	8e-06	0.000162	CcSEcCtD
Fluorouracil—Pain—Epirubicin—prostate cancer	7.92e-06	0.00016	CcSEcCtD
Fluorouracil—Nausea—Capecitabine—prostate cancer	7.9e-06	0.00016	CcSEcCtD
Fluorouracil—Dizziness—Prednisone—prostate cancer	7.83e-06	0.000159	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Doxorubicin—prostate cancer	7.81e-06	0.000158	CcSEcCtD
Fluorouracil—Insomnia—Doxorubicin—prostate cancer	7.75e-06	0.000157	CcSEcCtD
Fluorouracil—Paraesthesia—Doxorubicin—prostate cancer	7.7e-06	0.000156	CcSEcCtD
Fluorouracil—Dyspnoea—Doxorubicin—prostate cancer	7.64e-06	0.000155	CcSEcCtD
Fluorouracil—Feeling abnormal—Epirubicin—prostate cancer	7.63e-06	0.000155	CcSEcCtD
Fluorouracil—Somnolence—Doxorubicin—prostate cancer	7.62e-06	0.000154	CcSEcCtD
Fluorouracil—Dyspepsia—Doxorubicin—prostate cancer	7.55e-06	0.000153	CcSEcCtD
Fluorouracil—Vomiting—Prednisone—prostate cancer	7.53e-06	0.000152	CcSEcCtD
Fluorouracil—TYMS—Diflorasone—Prednisone—prostate cancer	7.52e-06	0.00751	CbGdCrCtD
Fluorouracil—Rash—Prednisone—prostate cancer	7.47e-06	0.000151	CcSEcCtD
Fluorouracil—Dermatitis—Prednisone—prostate cancer	7.46e-06	0.000151	CcSEcCtD
Fluorouracil—Decreased appetite—Doxorubicin—prostate cancer	7.45e-06	0.000151	CcSEcCtD
Fluorouracil—Headache—Prednisone—prostate cancer	7.42e-06	0.00015	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Doxorubicin—prostate cancer	7.4e-06	0.00015	CcSEcCtD
Fluorouracil—Urticaria—Epirubicin—prostate cancer	7.36e-06	0.000149	CcSEcCtD
Fluorouracil—Pain—Doxorubicin—prostate cancer	7.33e-06	0.000148	CcSEcCtD
Fluorouracil—Body temperature increased—Epirubicin—prostate cancer	7.32e-06	0.000148	CcSEcCtD
Fluorouracil—Feeling abnormal—Doxorubicin—prostate cancer	7.06e-06	0.000143	CcSEcCtD
Fluorouracil—Nausea—Prednisone—prostate cancer	7.04e-06	0.000142	CcSEcCtD
Fluorouracil—Hypersensitivity—Epirubicin—prostate cancer	6.83e-06	0.000138	CcSEcCtD
Fluorouracil—Urticaria—Doxorubicin—prostate cancer	6.81e-06	0.000138	CcSEcCtD
Fluorouracil—Body temperature increased—Doxorubicin—prostate cancer	6.78e-06	0.000137	CcSEcCtD
Fluorouracil—TYMS—Budesonide—Prednisone—prostate cancer	6.6e-06	0.00658	CbGdCrCtD
Fluorouracil—Pruritus—Epirubicin—prostate cancer	6.55e-06	0.000133	CcSEcCtD
Fluorouracil—Diarrhoea—Epirubicin—prostate cancer	6.34e-06	0.000128	CcSEcCtD
Fluorouracil—TYMS—Danazol—Prednisone—prostate cancer	6.32e-06	0.00631	CbGdCrCtD
Fluorouracil—Hypersensitivity—Doxorubicin—prostate cancer	6.32e-06	0.000128	CcSEcCtD
Fluorouracil—Dizziness—Epirubicin—prostate cancer	6.13e-06	0.000124	CcSEcCtD
Fluorouracil—Pruritus—Doxorubicin—prostate cancer	6.06e-06	0.000123	CcSEcCtD
Fluorouracil—Vomiting—Epirubicin—prostate cancer	5.89e-06	0.000119	CcSEcCtD
Fluorouracil—Diarrhoea—Doxorubicin—prostate cancer	5.86e-06	0.000119	CcSEcCtD
Fluorouracil—Rash—Epirubicin—prostate cancer	5.84e-06	0.000118	CcSEcCtD
Fluorouracil—Dermatitis—Epirubicin—prostate cancer	5.84e-06	0.000118	CcSEcCtD
Fluorouracil—Headache—Epirubicin—prostate cancer	5.8e-06	0.000118	CcSEcCtD
Fluorouracil—Dizziness—Doxorubicin—prostate cancer	5.67e-06	0.000115	CcSEcCtD
Fluorouracil—Nausea—Epirubicin—prostate cancer	5.5e-06	0.000111	CcSEcCtD
Fluorouracil—Vomiting—Doxorubicin—prostate cancer	5.45e-06	0.00011	CcSEcCtD
Fluorouracil—Rash—Doxorubicin—prostate cancer	5.4e-06	0.000109	CcSEcCtD
Fluorouracil—Dermatitis—Doxorubicin—prostate cancer	5.4e-06	0.000109	CcSEcCtD
Fluorouracil—Headache—Doxorubicin—prostate cancer	5.37e-06	0.000109	CcSEcCtD
Fluorouracil—Nausea—Doxorubicin—prostate cancer	5.09e-06	0.000103	CcSEcCtD
Fluorouracil—CYP1A2—Metabolism—GSTA1—prostate cancer	7.01e-07	1.71e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—MTHFR—prostate cancer	7.01e-07	1.71e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NCOA2—prostate cancer	6.97e-07	1.7e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NAT2—prostate cancer	6.93e-07	1.69e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—HSD3B2—prostate cancer	6.93e-07	1.69e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTO1—prostate cancer	6.93e-07	1.69e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NCOA2—prostate cancer	6.93e-07	1.69e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PPARA—prostate cancer	6.88e-07	1.68e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CB—prostate cancer	6.87e-07	1.68e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTEN—prostate cancer	6.83e-07	1.67e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYP1A1—prostate cancer	6.83e-07	1.67e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NCOA3—prostate cancer	6.8e-07	1.66e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ERCC2—prostate cancer	6.77e-07	1.65e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	6.68e-07	1.63e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	6.66e-07	1.63e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SLC5A5—prostate cancer	6.65e-07	1.62e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PLCB2—prostate cancer	6.64e-07	1.62e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—LRP2—prostate cancer	6.64e-07	1.62e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP2C18—prostate cancer	6.64e-07	1.62e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	6.63e-07	1.62e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SLC5A5—prostate cancer	6.61e-07	1.61e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—IL6—prostate cancer	6.57e-07	1.6e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CB—prostate cancer	6.54e-07	1.6e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—P4HB—prostate cancer	6.52e-07	1.59e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—EP300—prostate cancer	6.51e-07	1.59e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP2E1—prostate cancer	6.49e-07	1.58e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTGS2—prostate cancer	6.48e-07	1.58e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—HPGDS—prostate cancer	6.48e-07	1.58e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CAV1—prostate cancer	6.46e-07	1.58e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PIK3CA—prostate cancer	6.46e-07	1.58e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP2E1—prostate cancer	6.46e-07	1.58e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP2C19—prostate cancer	6.44e-07	1.57e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NQO1—prostate cancer	6.42e-07	1.57e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NQO1—prostate cancer	6.38e-07	1.56e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—MTHFR—prostate cancer	6.37e-07	1.55e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SLC22A1—prostate cancer	6.34e-07	1.55e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—TH—prostate cancer	6.33e-07	1.54e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IL2—prostate cancer	6.31e-07	1.54e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—TH—prostate cancer	6.29e-07	1.54e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTT1—prostate cancer	6.29e-07	1.53e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ACHE—prostate cancer	6.29e-07	1.53e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.29e-07	1.53e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.26e-07	1.53e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP3A4—prostate cancer	6.26e-07	1.53e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.25e-07	1.53e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PPARA—prostate cancer	6.25e-07	1.52e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	6.23e-07	1.52e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP3A4—prostate cancer	6.23e-07	1.52e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CA—prostate cancer	6.22e-07	1.52e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP2A6—prostate cancer	6.22e-07	1.52e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	6.19e-07	1.51e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	6.19e-07	1.51e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SULT2A1—prostate cancer	6.18e-07	1.51e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP1B1—prostate cancer	6.16e-07	1.5e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP1B1—prostate cancer	6.12e-07	1.49e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—MED12—prostate cancer	6.08e-07	1.48e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—AKT1—prostate cancer	6.06e-07	1.48e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AKR1C3—prostate cancer	6.05e-07	1.48e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GNG5—prostate cancer	6.03e-07	1.47e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PRKACB—prostate cancer	6.01e-07	1.47e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GGT1—prostate cancer	5.96e-07	1.46e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP17A1—prostate cancer	5.95e-07	1.45e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GGT1—prostate cancer	5.93e-07	1.45e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CG—prostate cancer	5.89e-07	1.44e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CAV1—prostate cancer	5.87e-07	1.43e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NCOA1—prostate cancer	5.87e-07	1.43e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.87e-07	1.43e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NCOA1—prostate cancer	5.84e-07	1.43e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NCOA3—prostate cancer	5.81e-07	1.42e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP19A1—prostate cancer	5.79e-07	1.41e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP19A1—prostate cancer	5.75e-07	1.4e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—IL6—prostate cancer	5.72e-07	1.4e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.71e-07	1.39e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NCOA2—prostate cancer	5.67e-07	1.38e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—EP300—prostate cancer	5.66e-07	1.38e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTEN—prostate cancer	5.65e-07	1.38e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—RXRA—prostate cancer	5.59e-07	1.36e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—INS—prostate cancer	5.57e-07	1.36e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—RXRA—prostate cancer	5.55e-07	1.36e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—HPGDS—prostate cancer	5.54e-07	1.35e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP2C19—prostate cancer	5.5e-07	1.34e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—SRC—prostate cancer	5.5e-07	1.34e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CREBBP—prostate cancer	5.46e-07	1.33e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.43e-07	1.33e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CA—prostate cancer	5.41e-07	1.32e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SLC5A5—prostate cancer	5.41e-07	1.32e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.4e-07	1.32e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—EP300—prostate cancer	5.39e-07	1.32e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—COMT—prostate cancer	5.38e-07	1.31e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ACHE—prostate cancer	5.37e-07	1.31e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTT1—prostate cancer	5.37e-07	1.31e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VEGFA—prostate cancer	5.36e-07	1.31e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTP1—prostate cancer	5.35e-07	1.31e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—COMT—prostate cancer	5.35e-07	1.31e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CG—prostate cancer	5.35e-07	1.31e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTP1—prostate cancer	5.32e-07	1.3e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP2A6—prostate cancer	5.31e-07	1.3e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.29e-07	1.29e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP2E1—prostate cancer	5.28e-07	1.29e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—AKT1—prostate cancer	5.28e-07	1.29e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ITPR1—prostate cancer	5.27e-07	1.29e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ITPR1—prostate cancer	5.24e-07	1.28e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NQO1—prostate cancer	5.23e-07	1.28e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.18e-07	1.26e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CD—prostate cancer	5.18e-07	1.26e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKR1C3—prostate cancer	5.17e-07	1.26e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.15e-07	1.26e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—TH—prostate cancer	5.15e-07	1.26e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PRKACB—prostate cancer	5.14e-07	1.25e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.12e-07	1.25e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP3A4—prostate cancer	5.1e-07	1.24e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP17A1—prostate cancer	5.09e-07	1.24e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—AKT1—prostate cancer	5.08e-07	1.24e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.07e-07	1.24e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—INS—prostate cancer	5.06e-07	1.24e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.02e-07	1.22e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP1B1—prostate cancer	5.01e-07	1.22e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—TYMS—prostate cancer	4.98e-07	1.22e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CREBBP—prostate cancer	4.96e-07	1.21e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—TYMS—prostate cancer	4.95e-07	1.21e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GSTM1—prostate cancer	4.92e-07	1.2e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TGFB1—prostate cancer	4.92e-07	1.2e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GSTM1—prostate cancer	4.89e-07	1.19e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—NOS3—prostate cancer	4.89e-07	1.19e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GGT1—prostate cancer	4.85e-07	1.18e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NCOA2—prostate cancer	4.85e-07	1.18e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—LPL—prostate cancer	4.83e-07	1.18e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CA—prostate cancer	4.82e-07	1.18e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—LPL—prostate cancer	4.8e-07	1.17e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NCOA1—prostate cancer	4.78e-07	1.17e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP19A1—prostate cancer	4.71e-07	1.15e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CD—prostate cancer	4.7e-07	1.15e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP1A1—prostate cancer	4.66e-07	1.14e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP1A1—prostate cancer	4.64e-07	1.13e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ERCC2—prostate cancer	4.63e-07	1.13e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SLC5A5—prostate cancer	4.62e-07	1.13e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ERCC2—prostate cancer	4.6e-07	1.12e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—KRAS—prostate cancer	4.56e-07	1.11e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—RXRA—prostate cancer	4.55e-07	1.11e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP2E1—prostate cancer	4.52e-07	1.1e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CB—prostate cancer	4.51e-07	1.1e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTGS2—prostate cancer	4.47e-07	1.09e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NQO1—prostate cancer	4.47e-07	1.09e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—NOS3—prostate cancer	4.44e-07	1.08e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.42e-07	1.08e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AKT1—prostate cancer	4.42e-07	1.08e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—TH—prostate cancer	4.4e-07	1.07e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—COMT—prostate cancer	4.38e-07	1.07e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.37e-07	1.07e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTP1—prostate cancer	4.36e-07	1.06e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP3A4—prostate cancer	4.35e-07	1.06e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—MTHFR—prostate cancer	4.35e-07	1.06e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.33e-07	1.06e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—MTHFR—prostate cancer	4.32e-07	1.06e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ITPR1—prostate cancer	4.29e-07	1.05e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP1B1—prostate cancer	4.28e-07	1.04e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PPARA—prostate cancer	4.27e-07	1.04e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PPARA—prostate cancer	4.24e-07	1.04e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.22e-07	1.03e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CA—prostate cancer	4.19e-07	1.02e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GGT1—prostate cancer	4.15e-07	1.01e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CB—prostate cancer	4.1e-07	1e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NCOA1—prostate cancer	4.08e-07	9.97e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTGS2—prostate cancer	4.06e-07	9.91e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—TYMS—prostate cancer	4.05e-07	9.89e-06	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—prostate cancer	4.05e-07	9.88e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP19A1—prostate cancer	4.02e-07	9.82e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CAV1—prostate cancer	4.01e-07	9.79e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GSTM1—prostate cancer	4e-07	9.78e-06	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CA—prostate cancer	3.99e-07	9.74e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CAV1—prostate cancer	3.99e-07	9.74e-06	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AKT1—prostate cancer	3.94e-07	9.61e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—LPL—prostate cancer	3.93e-07	9.6e-06	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTEN—prostate cancer	3.9e-07	9.52e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—RXRA—prostate cancer	3.88e-07	9.48e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.83e-07	9.35e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.81e-07	9.3e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP1A1—prostate cancer	3.8e-07	9.27e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.78e-07	9.22e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ERCC2—prostate cancer	3.77e-07	9.19e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—COMT—prostate cancer	3.74e-07	9.13e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTP1—prostate cancer	3.72e-07	9.09e-06	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—EP300—prostate cancer	3.72e-07	9.07e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ITPR1—prostate cancer	3.66e-07	8.94e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CG—prostate cancer	3.65e-07	8.92e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CG—prostate cancer	3.63e-07	8.87e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.6e-07	8.79e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTEN—prostate cancer	3.54e-07	8.65e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—MTHFR—prostate cancer	3.54e-07	8.64e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PPARA—prostate cancer	3.47e-07	8.48e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—TYMS—prostate cancer	3.46e-07	8.45e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—INS—prostate cancer	3.46e-07	8.44e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—INS—prostate cancer	3.44e-07	8.39e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GSTM1—prostate cancer	3.42e-07	8.35e-06	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—AKT1—prostate cancer	3.42e-07	8.35e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CREBBP—prostate cancer	3.39e-07	8.27e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—EP300—prostate cancer	3.38e-07	8.24e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CREBBP—prostate cancer	3.37e-07	8.22e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—LPL—prostate cancer	3.36e-07	8.2e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CAV1—prostate cancer	3.26e-07	7.97e-06	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AKT1—prostate cancer	3.26e-07	7.95e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP1A1—prostate cancer	3.24e-07	7.92e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ERCC2—prostate cancer	3.22e-07	7.85e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CD—prostate cancer	3.21e-07	7.84e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CD—prostate cancer	3.19e-07	7.8e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.12e-07	7.61e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NOS3—prostate cancer	3.03e-07	7.4e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—MTHFR—prostate cancer	3.02e-07	7.38e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NOS3—prostate cancer	3.02e-07	7.36e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CG—prostate cancer	2.97e-07	7.26e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PPARA—prostate cancer	2.97e-07	7.24e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—INS—prostate cancer	2.82e-07	6.87e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CB—prostate cancer	2.8e-07	6.83e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CAV1—prostate cancer	2.79e-07	6.81e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CB—prostate cancer	2.78e-07	6.79e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTGS2—prostate cancer	2.77e-07	6.77e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTGS2—prostate cancer	2.76e-07	6.73e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CREBBP—prostate cancer	2.76e-07	6.73e-06	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CA—prostate cancer	2.75e-07	6.71e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.67e-07	6.51e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CD—prostate cancer	2.61e-07	6.38e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CG—prostate cancer	2.54e-07	6.2e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CA—prostate cancer	2.5e-07	6.1e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NOS3—prostate cancer	2.47e-07	6.03e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTEN—prostate cancer	2.42e-07	5.91e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTEN—prostate cancer	2.41e-07	5.87e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—INS—prostate cancer	2.41e-07	5.87e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CREBBP—prostate cancer	2.36e-07	5.75e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—EP300—prostate cancer	2.31e-07	5.63e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—EP300—prostate cancer	2.29e-07	5.6e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CB—prostate cancer	2.28e-07	5.56e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTGS2—prostate cancer	2.26e-07	5.51e-06	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AKT1—prostate cancer	2.25e-07	5.48e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CD—prostate cancer	2.23e-07	5.45e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NOS3—prostate cancer	2.11e-07	5.15e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AKT1—prostate cancer	2.04e-07	4.98e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTEN—prostate cancer	1.97e-07	4.81e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.95e-07	4.75e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTGS2—prostate cancer	1.93e-07	4.71e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—EP300—prostate cancer	1.88e-07	4.58e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CA—prostate cancer	1.71e-07	4.17e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CA—prostate cancer	1.7e-07	4.14e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTEN—prostate cancer	1.68e-07	4.11e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—EP300—prostate cancer	1.6e-07	3.92e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AKT1—prostate cancer	1.39e-07	3.4e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.39e-07	3.39e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AKT1—prostate cancer	1.39e-07	3.38e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.19e-07	2.9e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AKT1—prostate cancer	1.13e-07	2.77e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKT1—prostate cancer	9.7e-08	2.37e-06	CbGpPWpGaD
